Sweden · Delayed Price · Currency is SEK Enorama Pharma AB Statistics
Total Valuation
STO:ERMA has a market cap or net worth of SEK 30.28 million. The enterprise value is 12.52 million.
| Market Cap | 30.28M |
| Enterprise Value | 12.52M |
Important Dates
The next estimated earnings date is Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ERMA has 74.59 million shares outstanding. The number of shares has increased by 30.99% in one year.
| Current Share Class | 74.59M |
| Shares Outstanding | 74.59M |
| Shares Change (YoY) | +30.99% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 20.38% |
| Owned by Institutions (%) | 1.69% |
| Float | 15.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.85 |
| PB Ratio | -0.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.19 |
| EV / Sales | 3.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64
| Current Ratio | 0.64 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -120.55% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 453.31% |
| Weighted Average Cost of Capital (WACC) | 13.06% |
| Revenue Per Employee | 771,200 |
| Profits Per Employee | -13.05M |
| Employee Count | 5 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.75% in the last 52 weeks. The beta is 1.60, so STO:ERMA's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | -85.75% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 56.56 |
| Average Volume (20 Days) | 56,628 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:ERMA had revenue of SEK 3.86 million and -65.27 million in losses.
| Revenue | 3.86M |
| Gross Profit | -5.63M |
| Operating Income | -56.32M |
| Pretax Income | -65.27M |
| Net Income | -65.27M |
| EBITDA | -56.24M |
| EBIT | -56.32M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 17.76 million in cash and n/a in debt, with a net cash position of 17.76 million or 0.24 per share.
| Cash & Cash Equivalents | 17.76M |
| Total Debt | n/a |
| Net Cash | 17.76M |
| Net Cash Per Share | 0.24 |
| Equity (Book Value) | -36.64M |
| Book Value Per Share | n/a |
| Working Capital | -12.60M |
Cash Flow
| Operating Cash Flow | -45.27M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 131,000 |
| Net Borrowing | 20.13M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -146.11% |
| Operating Margin | -1,460.45% |
| Pretax Margin | -1,692.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ERMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.99% |
| Shareholder Yield | -30.99% |
| Earnings Yield | -215.54% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |